Found 120 matching trials
Montelukast - a Treatment Choice for COVID-19
N/AThe current study aimed to make a therapeutic comparison and effectiveness ...
Location
Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China
Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia
PHASE2This single-center, prospective, open-label, comparator study, blind for ce...
PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)
PHASE2This is an open label controlled household-randomised trial designed to eva...
Location
Imperial College Healthcare NHS Trust
Addressing Vaccine Hesitancy and Increasing COVID-19 Vaccine Uptake Among African American Young Adults in the South
NAThe study staff will conduct a hybrid type 1 effectiveness implementation 2...
Location
Florida State University
Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO
NAGiven the likelihood of COVID-19 remaining an endemic disease among high-ri...
Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients With SARS-CoV-2 (COVID-19) Infection
PHASE2To study the efficacy and safety of icatibant in adult patients admitted to...
Location
Hospital Universitari de Bellvitge
Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19
PHASE1An open label clinical study to evaluate the safety and the efficacy of Mes...
Location
Kaplan Medical Center
The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients
PHASE2The (World Health Organization) WHO NOR- (Coronavirus infectious disease) C...
Location
Andreas Barratt-Due
Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia
PHASE2To study signals of efficacy and safety of a currently available dosage for...
Location
Multiple Locations
Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals
PHASE2This study is a 4-arm, multicenter, randomized, partly double- blind, contr...
Location
Abteilung Infektiologie Klinik für Innere Medizin II Department Innere Medizin Universitätsklinikum Freiburg